Cherine Eldumiati Plumaker - Co-Founder and General Partner, Pansend Life Sciences, LLC
Cherine E. Plumaker began her career at Weiss Peck & Greer-Farber Present Fund as an equity analyst focusing on the healthcare and consumer industries. In rapid succession, she became portfolio manager and ultimately Head of Trading and Senior Portfolio Manager of the Fund.
Upon the sale of Weiss Peck &Greer- Farber Present Fund to Robeco/Rabobank N.V., Ms. Plumaker partnered with Dr. Present and became Co-founder and Chief Operating Officer of Palyon Medical Corporation. In 2014 she co-founded Pansend Life Sciences LLC, a subsidiary of HC2 Holdings, Inc. (NYSE:HCHC) dedicated to investing broadly in life sciences and healthcare. Ms. Plumaker received a B.S in Economics from Rutgers University.
United States
425 N. New Ballas Road
Suite 100
St. Louis, MO 63141
P: (314) 735-0968
Germany
Cubex41
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
P: +49 (0)621-150283-15
Greater China
華東醫藥股份有限公司
聯繫電話:4008-269-985
+86-(0)571-89908581
郵遞區號:310011
地址:中國浙江省杭州市拱墅區莫幹山路866號
郵箱:info@eastchinapharm.com
* MediBeacon 的各個產品線均處於臨床開發的不同階段,尚未批准用於人體。
**經皮GFR監測系統(TGFR)用於檢查腎功能受損或正常人的腎絲球過濾率(GFR),本網站使用的文獻中涉及到的“腎臟功能”或者“腎功能”均指GFR檢測。
COOKIE CONSENT: We use cookies and similar technologies to recognize your repeat visits and preferences, as well as to analyze traffic, among other things. To learn more about cookies, view our Privacy Policy. By clicking “I Accept” on this banner, or using our site, you consent to the use of cookies unless you have disabled them.